Medicaid GLP-1 coverage in Iowa, 2026.

Iowa Medicaid does not cover Wegovy for weight loss.

What Iowa Medicaid actually covers for Wegovy, Zepbound, Ozempic and Mounjaro. Most state Medicaid programs still exclude weight-loss-indication GLP-1, but the diabetes path is covered nearly everywhere with prior authorization (your doctor asks the plan to approve it first). Here is the current 2026 reality for Iowa.

Coverage summary

IndicationCoverage
Wegovy (weight loss)No
Zepbound (weight loss)No
Ozempic / Mounjaro (type 2 diabetes)Yes
Compounded semaglutide / tirzepatideNo

Prior-authorization criteria

These rules come from the state preferred drug list (PDL), the list of drugs Iowa Medicaid has agreed to pay for.

CriterionValue
PA burdenMedium
BMI threshold (weight-loss path)Not applicable (weight-loss path not covered)
Comorbidity requiredNo
Last PDL update reviewed2025-Q3

What this means in practice

Iowa Health Link MCOs follow the state PDL exclusion of weight-loss GLP-1. Diabetes coverage with PA is standard.

Managed-care organizations in Iowa (3 contracted)

Iowa Medicaid contracts with the following managed-care organizations (MCOs), the private health plans the state pays to run day-to-day Medicaid coverage. MCO formularies must meet or exceed the state PDL but can layer in additional criteria. Verify your assigned MCO's most recent PA policy before submitting.

  • Amerigroup Iowa (Anthem)
  • Iowa Total Care (Centene)
  • Molina Healthcare of Iowa

Cash-pay alternatives if Medicaid does not cover you

If you end up paying cash, the GLP-1 cost guide breaks down what every legitimate path actually costs at maintenance dose, from the $149-a-month compounded floor to branded manufacturer-direct pricing. For ranked cash-pay options, see programs ranked by price and programs under $150 a month. Manufacturer savings cards and patient-assistance programs are not routes here: federal law bars the cards for anyone on Medicaid, and the free-drug programs require being uninsured.

Two routes sit outside Medicaid entirely. If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.

For the full cash-pay picture specific to Iowa, including which programs serve Iowa residents and the Iowa Medicaid cost comparison, see the cheapest GLP-1 in Iowa guide.

Take it to your prescriber: PA letter library

If you qualify under one of the covered indications above, the prior-authorization route is the cheapest path. We maintain a PA letter library with templates for Aetna, Cigna, UnitedHealthcare, Anthem BCBS, Kaiser, Humana, Tricare, FEHB and Medicare Advantage, cross-indexed against six qualifying clinical pictures. Each template cites the plan's policy document, the qualifying ICD-10 codes and the registration-trial evidence.

If you have type 2 diabetes plus chronic kidney disease and established cardiovascular disease, the triple-indication evidence stack (FLOW + SELECT + SUSTAIN-6) is the strongest PA path in any state.

If your PA is denied, the appeal letter library has denial-specific templates. For the commercial and Medicare coverage paths, see the GLP-1 insurance guide.

Iowa Medicaid GLP-1 FAQ

Does Iowa Medicaid cover Wegovy for weight loss?
No. Iowa Medicaid does not cover Wegovy for the weight-loss indication as of the 2025-Q3 preferred drug list review. If you have type 2 diabetes, the diabetes-indicated GLP-1s (Ozempic, Mounjaro) may still be covered with prior authorization.
Does Iowa Medicaid cover Zepbound for weight loss?
No. Iowa Medicaid does not cover Zepbound for the weight-loss indication as of the 2025-Q3 preferred drug list review. If you have type 2 diabetes, Mounjaro (tirzepatide, the same molecule as Zepbound) may be covered with prior authorization under the diabetes pathway.
Does Iowa Medicaid cover Ozempic or Mounjaro for diabetes?
Yes. Iowa Medicaid covers Ozempic and Mounjaro for type 2 diabetes with prior authorization, usually after a trial of metformin. The diabetes pathway does not carry the BMI threshold that applies to the weight-loss pathway.
What if Iowa Medicaid does not cover my GLP-1?
If your GLP-1 is not covered, the routes left do not run through Medicaid. A clinical trial costs nothing and many pay you for your time, and nobody checks your income. Some participants get a placebo, decided at random. Manufacturer savings cards are not a route here, because federal law bars them for anyone on Medicaid. Cash-pay compounded semaglutide starts around $149 a month. If you were denied, the appeal letter library has denial-specific templates.

Other state Medicaid pages

See the full 51-state coverage table for the side-by-side view across every US state.

How we built this page

Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.

Last updated: 2026-07-20. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Iowa Medicaid, email hello@glpchart.com with the details and we will check it.

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.